Lupus is most commonly divided into two main types: systemic lupus erythematosus (SLE), which affects multiple organs throughout the body, and cutaneous lupus erythematosus (CLE), which is limited to the skin. These are the two forms most people encounter, but there are actually four recognized types of lupus. Drug-induced lupus and neonatal lupus round out the list, each with distinct causes and outcomes.
Systemic Lupus Erythematosus (SLE)
SLE is the most common and most serious form. An estimated 204,000 people in the United States have it, and roughly 9 out of 10 are women. In SLE, the immune system produces antibodies that mistakenly target the body’s own DNA and proteins, triggering widespread inflammation. This inflammation can damage virtually any organ, which is why the disease looks so different from one person to the next.
The joints, skin, and kidneys are the most frequently affected. Kidney involvement, called lupus nephritis, happens when immune complexes deposit in the kidney’s filtering units, activating the body’s inflammatory cascade and gradually damaging tissue. Left unmanaged, this can progress to serious kidney failure. Doctors monitor for it with urine tests that check for protein and blood cells, and a kidney biopsy is often needed to determine how severe the damage is.
Beyond the kidneys, SLE can affect the cardiovascular system and the central nervous system. Each person tends to develop their own distinct pattern of organ involvement. Common day-to-day symptoms include joint pain and swelling, extreme fatigue, fevers, and a butterfly-shaped rash across the cheeks and nose. Flares can come and go unpredictably, often triggered by stress, sunlight, or infection.
Diagnosis follows a point-based system. A positive antinuclear antibody (ANA) test at a specific threshold is the entry requirement, and then doctors tally points across clinical and immunological criteria. A score of 10 or more supports a classification of SLE.
Cutaneous Lupus Erythematosus (CLE)
CLE is less common than SLE and stays confined to the skin. It comes in three subtypes: discoid lupus, subacute cutaneous lupus, and acute cutaneous lupus.
Discoid lupus is the most well-known form. It produces thick, coin-shaped lesions, usually on the face, ears, and scalp. These lesions can cause permanent scarring and hair loss if they develop in hair-bearing areas. Subacute cutaneous lupus tends to appear as ring-shaped or scaly patches on sun-exposed areas like the arms, chest, and upper back. It generally doesn’t scar. Acute cutaneous lupus is the type responsible for the classic butterfly rash across the cheeks, and it often overlaps with systemic disease.
One important thing to know: discoid lupus can progress to systemic lupus. A systematic review found the risk ranges from about 6% to 21%, depending on the study population. In one registry-based study tracking 74 patients with cutaneous lupus, about 7% developed moderate or severe systemic disease over a roughly three-year follow-up period. This is relatively uncommon, but it’s the reason doctors monitor CLE patients for signs of internal organ involvement over time.
Drug-Induced Lupus
Drug-induced lupus develops as a side effect of certain medications. The symptoms closely resemble SLE, including joint pain, fatigue, and fever, but they rarely involve serious organ damage like kidney disease. The key difference is that this form is reversible. Symptoms typically go away within days to weeks after stopping the medication that triggered them.
The most common culprits include isoniazid (a tuberculosis drug), hydralazine (used for high blood pressure), procainamide (a heart rhythm medication), minocycline (an antibiotic), and TNF-alpha inhibitors used for autoimmune conditions like rheumatoid arthritis. Some cancer immunotherapy drugs and anti-seizure medications can also trigger it. Even levamisole, a contaminant sometimes found in cocaine, has been linked to drug-induced lupus.
Neonatal Lupus
Neonatal lupus is rare and affects newborns. It isn’t caused by the baby’s own immune system going haywire. Instead, it occurs when specific antibodies from the mother cross the placenta during pregnancy. These antibodies, called anti-Ro/SSA and anti-La/SSB, can be present even in women who have no lupus symptoms themselves.
The two main concerns are skin rashes and heart problems. Skin involvement appears in roughly 4% to 16% of babies born to mothers carrying these antibodies, and it typically resolves on its own as the maternal antibodies clear from the infant’s system. The heart complications are more serious. About 2% to 4% of these babies develop congenital heart block, a condition where electrical signals between the upper and lower chambers of the heart are disrupted. Complete heart block is the most characteristic finding, and roughly 20% of affected infants also develop or later show signs of cardiomyopathy, where the heart muscle itself is weakened.
How the Types Relate to Each Other
These four types are distinct conditions, not stages of the same disease. Having cutaneous lupus doesn’t mean you’ll develop systemic lupus, though there’s a small chance of progression. Drug-induced lupus resolves and doesn’t turn into SLE. Neonatal lupus is tied to maternal antibodies and typically clears as the baby grows.
That said, there’s overlap. People with SLE often develop skin rashes that look identical to cutaneous lupus. The butterfly rash of acute cutaneous lupus frequently occurs alongside systemic disease. What separates CLE as its own diagnosis is the absence of internal organ involvement. If blood work and clinical evaluation show that the disease is limited to the skin, the diagnosis stays cutaneous rather than systemic.